Sanofi and NIH chart early success with 3-part antibody against HIV When it comes to combating HIV, three virus-killing antibodies should be better than one, scientists at French pharma giant […]
With its Remicade biosimilar stymied by the brand, Pfizer sues Johnson & Johnson for ‘anticompetitive’ dealmaking Two pharma giants are squaring off on a first-of-a-kind lawsuit over the budding biosimilar business in […]
State AGs band together for stepped-up probe into opioid drug marketing After years of going it alone in investigating opioid drugmakers, attorneys general across the U.S. are joining forces to drill […]
Lightstone goes over target with new 0M biotech fund There’s a lot of money around for young biotechs at the moment. After Flagship said this week it was seeking a […]
Injunction denied: Pharma argument fails to freeze Nevada drug pricing law Drug pricing regulation hasn’t gained much ground on a national level, but in Nevada, there’s a fierce fight over […]